Wild, C. and Jonas, S. (2000): [Symposium "Evidence-based Medicine"]. ITA-Newsletter December 2000: pp. 8-9.

Wild, C. (2000): [HTA and decision making]. TA-Datenbank-Nachrichten 09 (04): pp. 152-153.

Wild, C. and Jonas, S. (2000): [HTA-workshop of European social insurance agencies]. ITA-Newsletter December 2000: p. 8.

Wild, C. (2000): [The C-reactive protein test in the diagnosis of infections]. ITA-Newsletter September 2000: p. 3.

Wild, C. (2000): [ISTHAC 2002 in Berlin]. ITA-Newsletter September 2000: p. 8.

Wild, C. and Jonas, S. (2000): [EPO in cancer anaemia]. ITA-Newsletter September 2000: pp. 2-3.

Wild, C. and Torgersen, H. (2000): Forecasting in medicine: The results of three European Delphi Studies. European Journal of Public Health 10 (02): pp. 114-119.

Wild, C. and Jonas, S. (2000): [Erythropoietin in tumour anaemia. An assessment]. ITA-Projektbericht 15.

Wild, C. and Hahn, R. (2000): [Near-patient CRP testing by physicians in private practice to reduce antibiotic prescriptions]. ITA-Projektbericht 16.

Wild, C. (2000): Country report: Health technology assessment in Austria. International Journal of Technology Assessment in Health Care 16 (02): pp. 303-324.

Wild, C. (2000): [HTA and decision making]. ITA-Newsletter April 2000: p. 6.

Wild, C. (2000): [EPO for cancer related anaemia]. ITA-Newsletter April 2000: p. 5.

Wild, C. and Khene, M. and Wanke, S. (2000): ESWT: Extracorporeal shock wave therapy - Assessment of an emerging health technology. International Journal of Technology Assessment in Health Care 16 (01): pp. 199-209.

Wild, C. (2000): [Erythropoietin in patients with fatigue syndrome]. forum dr. Med. (13): pp. 4-5.

Wild, C. (2000): [Health technology assessment: A steering tool]. Mitteilung der Sanitätsverwaltung (01): pp. 6-8.

Wild, C. (2000): Health technology assessment. In: Fischer, R. and Tragl, H. Ökonomie und Gesundheit. Lösbare Herausforderungen oder dauernder Widerspruch?: Wien: Österreichischer Ärzte Verlag, pp. 249-264.

Wild, C. and Jonas, S. (2000): [Erythropoietin (EPO) in tumour anaemia]. Newsletter der Österreichischen Gesellschaft für Public Health (4): pp. 1-2.